Reduction of expression of tuberin, the tuberous-sclerosis-complex-gene-2 product in tuberous sclerosis complex associated connective tissue nevi and sporadic squamous and basal cell carcinomas

Journal of Cutaneous Pathology

Volumn 29, Issue 5, 2002, Pages 287-290

  Wienecke, Ralf ^a,b   Klemm, Eckart ^a,b   Karparti, Sarolta ^c   Swanson, Neil A ^d   Green, Andrew J ^e   DeClue, Jeffrey E ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b NATIONAL CANCER INSTITUTE   (United States)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; TUBERIN; REPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BASAL CELL CARCINOMA; CONNECTIVE TISSUE DISEASE; DOWN REGULATION; HAMARTOMA; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; NEVUS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUBEROUS SCLEROSIS; BIOSYNTHESIS; COMPARATIVE STUDY; CONNECTIVE TISSUE; EPITHELIUM; GENETICS; METABOLISM; SKIN TUMOR; TUMOR SUPPRESSOR GENE;

CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; COMPARATIVE STUDY; CONNECTIVE TISSUE; EPITHELIUM; GENES, TUMOR SUPPRESSOR; HUMAN; IMMUNOBLOTTING; NEVUS, INTRADERMAL; REPRESSOR PROTEINS; SKIN NEOPLASMS; SUPPORT, NON-U.S. GOV'T; TUBEROUS SCLEROSIS; HUMANS; TUMOR SUPPRESSOR PROTEINS;

EID: 0036020483     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0560.2002.290505.x     Document Type: Article

References (17)

1. Toward a survey of somatic mutation of the NF1 gene in benign neurofibromas of patients with neurofibromatosis type 1
2. Mutation and childhood cancer: A probabilistic model for the incidence of retinoblastoma
3. Molecular genetic advances in tuberous sclerosis
4. Skin lesions in children with tuberous sclerosis complex. Their prevalence, natural course, and diagnostic significance
5. Dermatologic manifestations
6. Identification and characterization of the tuberous sclerosis gene on chromosome 16
7. Loss of heterozygosity in tuberous sclerosis hamartomas
8. Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region
9. Enhanced cardiomyocyte DNA synthesis during myocardial hypertrophy in mice expressing a modified TSC2 transgene
10. Loss of tuberin, the tuberous-sclerosis-complex-2 gene product is associated with angiogenesis
11. Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas
12. Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues
13. Co-localization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus
14. Allelic loss at the tuberous sclerosis 2 locus in spontaneous tumors in the Eker rat
15. Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions
16. The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination
17. Survey of somatic mutations in tuberous sclerosis complex (tsc) hamartomas suggests different genetic mechanisms for pathogenesis of tsc lesions